ClinicalTrials.gg
CompletedNCT06586138STAYAWAKEUpdated Jun 5, 2026

Study of Psychological, Sociological and Professional Factors Associated With Maintenance of Wakefulness Test

An observational study in Narcolepsy and Obstructive Sleep Apnea (OSA), sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-05.

Sponsored by Hospices Civils de Lyon · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
103
Ages
18 Years and older
Sex
All
01

Study summary

The predictors of objective impaired alertness assessed by Maintenance of Wakefulness Tests (MWT) are poorly understood. Identifying such predictors are essential from a clinical point of view and from a pathophysiological perspective, to better understand the determinants of residual Excessive Daytime Sleepiness (EDS) and the complex link between subjective and objective impairments.

Also, the objective of this study is to describe psychological but also sociological and professional factors associated with Maintenance of Wakefulness Tests results.

02

Conditions studied

  • Narcolepsy
  • Obstructive Sleep Apnea (OSA)

Keywords

  • Obstructive Sleep Apnea
  • Maintenance of Wakefulness Test (MVT)
  • Anxiety
  • Alertness
  • Sleepiness
  • Narcolepsy
03

In context

Narcolepsy

157 studies on the registry are indexed under Narcolepsy; 37 are open to participants now.

This study's enrollment of 103 is below the median of 135 across 38 observational studies indexed under Narcolepsy.

Browse Narcolepsy studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,866 studies on the registry; 448 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Consecutive patients referred for Maintenance of Wakefulness test at the center for Sleep Medicine in Lyon University hospital (HCL - Croix Rousse)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult (i.e. age ≥ 18 y.o)
  • referred for Maintenance of Wakefulness test at Lyon University hospital (HCL - Croix Rousse Hospital)

Exclusion criteria

Exclusion Criteria:

  • do not consent
  • unable to answer the questionary
  • cognitive impairments
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
103 participants (actual)
Patient registry
No

Groups and cohorts

  • Maintenance of Wakefulness Test

    Consecutive patients referred for Maintenance of Wakefulness test at the center for Sleep Medicine in Lyon University hospital (HCL - Croix Rousse Hospital)

    Other: STAI (State-Trait Anxiety Inventory) Scale : Psychological inventory of 20 self-report items on a 4-point scale

Interventions

  • OtherSTAI (State-Trait Anxiety Inventory) Scale : Psychological inventory of 20 self-report items on a 4-point scale

    Patient completed STAI Scale in the 24 hours before Maintenance of Wakefulness Test during the hospitalization

06

What researchers measure

Primary outcomes

  1. State-Trait Anxiety Inventory (STAI) score

    STAI ((State-Trait Anxiety Inventory) scale is a psychological inventory of 20 self-report items on a 4-point scale. Minimum Score is 20 and maximum score is 80.

    Time frame: baseline

07

Study locations

1 site
  • Service de Médecine du Sommeil - Hopital Croix Rousse
    Lyon, France 69004, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06586138
Responsible party
Sponsor
First posted
Sep 19, 2024
Start date
Oct 18, 2024
Primary completion
Aug 14, 2025
Completion
Aug 14, 2025
Last update
Jun 5, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion